Pulmonary allograft ischemic time: An important predictor of survival after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 15, Issue 2, 1996, Pages 160-168

  Snell, G I ^a   Rabinov, M ^a   Griffiths, A ^a   Williams, T ^a   Ugoni, A ^a   Salamonsson, R ^a   Esmore, D ^a  

^a ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; EURO COLLINS SOLUTION; GANCICLOVIR; ITRACONAZOLE; OKT 3; PREDNISOLONE; PROSTACYCLIN; THYMOCYTE ANTIBODY;

ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIA; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; ORGAN PRESERVATION; PRIORITY JOURNAL; SURVIVAL;

ADULT; CONFIDENCE INTERVALS; FEMALE; GRAFT SURVIVAL; HEART-LUNG TRANSPLANTATION; HUMANS; LUNG TRANSPLANTATION; MALE; PROGNOSIS; REPERFUSION INJURY; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TISSUE PRESERVATION;

EID: 0029877196     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)